Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks
Abstract
IDH-mutant glioblastoma is classified by the 2016 CNS WHO as a group with good prognosis. However, the actual number of cases examined in the literature is relatively small. We hypothesize that IDH-mutant glioblastoma is not a uniform group and should be further stratified.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 01, 2019
- Source ID
- 10.1093/noajnl/vdz015
Entities
People
- Aden Ka-yin Chan
- Ho-keung Ng
- Hong Chen
- Houtan Noushmehr
- Johnny Sheung Him Kwan
- Kay Ka-wai Li
- Rui Ryan Yang
- Shaz Cheng
- Tathiane M. Malta
- Wai Sang Poon
- Ying Mao
- Zhi-feng Shi
Organizations
- Fudan University
- Henry Ford Health
- National Cancer Institute
- The Chinese University of Hong Kong
- United States Department of Defense